Aligos Therapeutics Mourns the Passing of MASH Industry Lead

SOUTH SAN FRANCISCO, Calif., April 25, 2024 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in...

Related Keywords

Lawrence Blatt , Jordyn Tarazi , Stephena Harrison , Michael Fitzhugh , Exchange Commission , Aligos Therapeutics Inc , Lifesci Communications , Principal Investigator For The Company , Investor Relations Corporate Communications , Exchange Commission On , Nasdaq , Principal Investigator , Chief Executive Officer , Securities Litigation Reform Act , Aligo Quarterly Report , Investor Relations , Markets ,